IOBT - IO Biotech Announces Participation in Upcoming Investor Conferences | Benzinga
NEW YORK, Sept. 06, 2023 (GLOBE NEWSWIRE) -- IO Biotech (NASDAQ:IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulating cancer vaccines based on its T-win® technology platform, today announced its participation in the upcoming investor conferences:
Event: Morgan Stanley 21st Annual Global Healthcare Conference
Location: New York, New York
Fireside Chat Date & Time: Tuesday, September 12, 2023 at 4:15 pm ET
Presenter: Mai-Britt Zocca, PhD, CEO
Webcast Link: Here
Event: H.C. Wainwright 25th Annual Global Investment Conference
Location: New York, New York
Presentation Time: Wednesday, September 13, 2023 at 2:00 pm ET
Presenter: Mai-Britt Zocca, PhD, CEO
Webcast Link: Here
A webcast replay of the presentations will be available on IO Biotech's website at www.iobiotech.com for 90 days following the presentation.
About IO102-IO103
IO102-IO103 is an investigational immune-modulating cancer vaccine designed to target the immunosuppressive mechanisms mediated by the proteins indoleamine 2,3-dioxygenase ...